- Bevorzugter Name
- 3-[(3R,4R)-3-[6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl(methyl)amino]-4-methylpiperidin-1-yl]-3-oxopropanenitrile;2-hydroxypropane-1,2,3-tricarboxylic acid
- IUPAC
- 3-[(3R,4R)-3-[6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl(methyl)amino]-4-methylpiperidin-1-yl]-3-oxopropanenitrile;2-hydroxypropane-1,2,3-tricarboxylic acid
- Englischer Name
- 1-Piperidinepropanenitrile, 3-[(6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl)methylamino]-4-methyl-β-oxo-, (3R,4R)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1)
- Summenformel
- C22H30N6O8
- Molmasse
- 506.52
Namen und Synonyme
1809002-40-13-((3R,4R)-3-((6,7-Dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl)(methyl)amino)-4-methylpiperidin-1-yl)-3-oxopropanenitrile 2-hydroxypropane-1,2,3-tricarboxylateTofacitinib Impurity N (Citrate)Tofacitinib Related Compound 21 Citrate1-Piperidinepropanenitrile, 3-[(6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl)methylamino]-4-methyl-β-oxo-, (3R,4R)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1)1-Piperidinepropanenitrile, 3-[(6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl)methylamino]-4-methyl-β-oxo-, (3R,4R)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1)